Onoue Takeshi, Nishida Kazuki, Nakata Yoshio, Hayashi Fumi, Marutani Miki, Sakane Naoki, Moriguchi Jiro, Muto Shigeki, Kato Kiminori, Masuda Izuru, Okamura Tomonori, Matsuzaki Keiichi, Kawamura Takashi, Tsushita Kazuyo
Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
J Occup Health. 2025 Jan 7;67(1). doi: 10.1093/joccuh/uiaf036.
Use of commercially available mobile health (mHealth) applications in supporting lifestyle improvements has become popular in recent years. However, the effectiveness of advice promoting the use of such applications based on individual behavioral goals in a health guidance setting remains unclear. This study explored how guiding participants of the Specific Health Guidance (SHG) program, a Japanese public health initiative to prevent cardiovascular disease, to use commercially available mHealth applications impacted their application usage, lifestyle habits, and cardiovascular risk factors.
In this multicenter, randomized, open-label, parallel-group comparison study, 156 individuals with a history of SHG participation and who were engaged in the Motivational Health Guidance program (a type of SHG) in 2021 were assigned to intervention (n = 76) or control (n = 80) groups. Whereas both groups received standard guidance, the intervention group also received recommendations for mHealth applications based on their individual behavioral goals. The participants' application usage, behavioral changes, and body weight were assessed after 3 months, with health checkup data evaluated after 1 year.
The proportion of mHealth application users after 3 months was significantly higher in the intervention group (68.4%) than in the control group (40.0%). The intervention group also reported a significantly greater weekly frequency of mHealth application usage. Moreover, the intervention group reported a significantly decreased change in triglyceride levels after 1 year compared with the control group.
Recommending commercially available mHealth applications in a health guidance setting significantly increased the number of mHealth application users and their frequency of use.
近年来,使用商业移动健康(mHealth)应用程序来支持改善生活方式变得很流行。然而,在健康指导环境中,基于个人行为目标促进使用此类应用程序的建议的有效性仍不明确。本研究探讨了指导日本一项预防心血管疾病的公共卫生倡议——特定健康指导(SHG)计划的参与者使用商业mHealth应用程序如何影响他们对应用程序的使用、生活习惯和心血管危险因素。
在这项多中心、随机、开放标签、平行组比较研究中,将156名有SHG参与史且在2021年参加动机性健康指导计划(一种SHG)的个体分为干预组(n = 76)或对照组(n = 80)。两组均接受标准指导,而干预组还根据其个人行为目标获得了mHealth应用程序的推荐。3个月后评估参与者的应用程序使用情况、行为变化和体重,1年后评估健康检查数据。
3个月后,干预组中mHealth应用程序用户的比例(68.4%)显著高于对照组(40.0%)。干预组还报告了mHealth应用程序每周使用频率显著更高。此外,与对照组相比,干预组报告1年后甘油三酯水平的变化显著降低。
在健康指导环境中推荐商业mHealth应用程序显著增加了mHealth应用程序用户的数量及其使用频率。